Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Konstantinos, Raisakis"'
Autor:
Konstantinos A. Papathanasiou, Dimitrios A. Vrachatis, Dimitrios Kazantzis, Charalampos Kossyvakis, Sotiria G. Giotaki, Gerasimos Deftereos, Konstantinos Raisakis, Andreas Kaoukis, Dimitrios Avramides, Vaia Lambadiari, Gerasimos Siasos, Spyridon Deftereos
Publikováno v:
The Egyptian Heart Journal, Vol 75, Iss 1, Pp 1-13 (2023)
Abstract Background Left atrium changes are implicated in atrial fibrillation (AF) substrate and are predictive of AF outcomes. Left atrial appendage (LAA) is an integral component of left atrial structure and could be affected by atrial cardiomyopat
Externí odkaz:
https://doaj.org/article/28211b775e834fd88d4136aba68a3f36
Autor:
Dimitrios A. Vrachatis, George V. Giannopoulos, Sotiria G. Giotaki, Konstantinos Raisakis, Charalampos Kossyvakis, Konstantinos E. Iliodromitis, Bernhard Reimers, Dimitrios Tousoulis, Michael Cleman, Christodoulos Stefanadis, Alexandra Lansky, Spyridon G. Deftereos
Publikováno v:
Hellenic Journal of Cardiology, Vol 62, Iss 5, Pp 374-377 (2021)
Externí odkaz:
https://doaj.org/article/a869b498aed8479c82486d97d1a2e7cb
Autor:
Dimitrios A. Vrachatis, Michail Vavuranakis, Styliani Tsoukala, Sotiria Giotaki, Theodore G. Papaioannou, Gerasimos Siasos, Gerasimos Deftereos, Georgios Giannopoulos, Konstantinos Raisakis, Dimitrios Tousoulis, Spyridon Deftereos, Manolis Vavuranakis
Publikováno v:
Hellenic Journal of Cardiology, Vol 61, Iss 3, Pp 148-153 (2020)
Transcatheter aortic valve implantation (TAVI) led to the foundation of the subspecialty of structural heart interventions and created an emerging area of clinical and technical issues. Soon after TAVI introduction into clinical practice, boundaries
Externí odkaz:
https://doaj.org/article/dfa131304b9e4a8ba8c6c3feabc0bd88
Autor:
Spyridon G. Deftereos, Gerasimos Siasos, Georgios Giannopoulos, Dimitrios A. Vrachatis, Christos Angelidis, Sotiria G. Giotaki, Panagiotis Gargalianos, Helen Giamarellou, Charalampos Gogos, Georgios Daikos, Marios Lazanas, Pagona Lagiou, Georgios Saroglou, Nikolaos Sipsas, Sotirios Tsiodras, Dimitrios Chatzigeorgiou, Nikolaos Moussas, Anastasia Kotanidou, Nikolaos Koulouris, Evangelos Oikonomou, Andreas Kaoukis, Charalampos Kossyvakis, Konstantinos Raisakis, Katerina Fountoulaki, Mihalis Comis, Dimitrios Tsiachris, Eleni Sarri, Andreas Theodorakis, Luis Martinez-Dolz, Jorge Sanz-Sánchez, Bernhard Reimers, Giulio G. Stefanini, Michael Cleman, Dimitrios Filippou, Christoforos D. Olympios, Vlasios N. Pyrgakis, John Goudevenos, George Hahalis, Theofilos M. Kolettis, Efstathios Iliodromitis, Dimitrios Tousoulis, Christodoulos Stefanadis
Publikováno v:
Hellenic Journal of Cardiology, Vol 61, Iss 1, Pp 42-45 (2020)
Objective: Colchicine has been utilized safely in a variety of cardiovascular clinical conditions. Among its potential mechanisms of action is the non-selective inhibition of NLRP3 inflammasome which is thought to be a major pathophysiologic componen
Externí odkaz:
https://doaj.org/article/126a11eb819443e8aea8ad9261344e17
Autor:
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Dimitrios Kazantzis, Jorge Sanz-Sánchez, Sotiria G. Giotaki, Konstantinos Raisakis, Andreas Kaoukis, Charalampos Kossyvakis, Gerasimos Deftereos, Bernhard Reimers, Dimitrios Avramides, Gerasimos Siasos, Michael Cleman, George Giannopoulos, Alexandra Lansky, Spyridon Deftereos
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1026 (2022)
Isolated coronary artery ectasia (CAE) is a relatively rare clinical entity, the pathogenesis of which is poorly understood. More and more evidence is accumulating to suggest a critical inflammatory component. We aimed to elucidate any association be
Externí odkaz:
https://doaj.org/article/f460e1d0aaa8453f9fbda2b1a58a73e6
Autor:
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Sotiria G. Giotaki, Konstantinos Raisakis, Andreas Kaoukis, Charalampos Kossyvakis, Andreas Theodorakis, Stauros Pediotidis, Dimitrios Avramides, Gerasimos Siasos, Spyridon Deftereos
Publikováno v:
Current Pharmaceutical Design. 29:509-518
Abstract: Heart failure with reduced ejection fraction (HFrEF) has been associated with poor prognosis, reduced quality of life, and increased healthcare expenditure. Despite tremendous advances in HFrEF management, reduced survival and a high rate o
Autor:
Konstantinos A. Papathanasiou, Sotiria G. Giotaki, Dimitrios A. Vrachatis, Gerasimos Siasos, Vaia Lambadiari, Konstantinos E. Iliodromitis, Charalampos Kossyvakis, Andreas Kaoukis, Konstantinos Raisakis, Gerasimos Deftereos, Theodore G. Papaioannou, Georgios Giannopoulos, Dimitrios Avramides, Spyridon G. Deftereos
Publikováno v:
Diagnostics, Vol 11, Iss 9, p 1584 (2021)
The prevalence of atrial fibrillation (AF) is bound to increase globally in the following years, affecting the quality of life of millions of people, increasing mortality and morbidity, and beleaguering health care systems. Increasingly effective the
Externí odkaz:
https://doaj.org/article/57ee0c57557a462186514a7a8b8f3a79
Autor:
Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Charalampos Kossyvakis, Dimitrios Kazantzis, Sotiria G. Giotaki, Gerasimos Deftereos, Jorge Sanz‐Sánchez, Konstantinos Raisakis, Andreas Kaoukis, Dimitrios Avramides, Vaia Lambadiari, Gerasimos Siasos, George Giannopoulos, Spyridon Deftereos
Publikováno v:
Journal of Cardiovascular Electrophysiology. 33:527-539
Early arrhythmia recurrence within the 3-month blanking period is a common event that historically has been attributed to reversible phenomena. While its mechanistic links remain obscure, accumulating evidence support the argument of shortening the b
Autor:
Dimitrios Avramides, Konstantinos Iliodromitis, Charalampos Kossyvakis, Konstantinos A. Papathanasiou, Georgios Giannopoulos, Michael W. Cleman, Spyridon Deftereos, Alexandra J. Lansky, Dimitrios A. Vrachatis, Giulio G. Stefanini, Bernhard Reimers, Sotiria G. Giotaki, Vaia Lambadiari, Andreas Kaoukis, Konstantinos Raisakis
Publikováno v:
Drugs. 81:1381-1395
The global burden of atrial fibrillation (AF) is constantly increasing, necessitating novel and effective therapeutic options. Sodium glucose co-transporter 2 (SGLT2) inhibitors have been introduced in clinical practice as glucose-lowering medication
Autor:
Lampros K. Michalis, Charalambos Karvounis, Vasilios Vasilikos, Dimitrios Stakos, Michalis Hamilos, Ioannis Anastasiou, Ioannis Tsiafoutis, Panos E. Vardas, John Kanakakis, George Hahalis, John A. Goudevenos, Konstantinos Raisakis, Michalis Koutouzis
Publikováno v:
EuroIntervention. 16:1163-1169
AIMS We aimed to demonstrate whether coronary microvascular function is improved after ticagrelor administration compared to clopidogrel administration in STEMI subjects undergoing thrombolysis. METHODS AND RESULTS MIRTOS is a multicentre study of ti